RxDoctor Payments Data

Ira Harber, MD

Dermatology · Corinth, MSNPI 1922539071

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,301 of the $7,088 with a category attached, or 88.9%. It is spread thinly across 29 manufacturers, the largest accounting for just 22.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,125, 8.3 times the $255 reported in 2019.

$7,088in general payments, 2019–2025

Across 330 payments — averaging $21.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$2K
  • AbbVie$1K
  • Johnson & Johnson$1K
  • Sun Pharmaceutical Industries Inc.$569
  • E.r. Squibb & Sons, L.L.C.$356
  • Regeneron Healthcare Solutions, Inc.$354
  • plus $2K from 23 others

What the payments were for

  • Food & beverage$6,30189%
  • Education$78711%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,088 in reported general payments places this provider in the 60th percentile of 78 dermatology providers in Mississippi.

See all dermatology providers in Mississippi

Medicare billing

Part B allowed, 2024
$1,274,259
Medicare patients
1,910
Services billed
16,235

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab14$129,175
Cosentyx Sensoready (2 Pens)Secukinumab15$108,567
Dupixent PenDupilumab29$104,837
Cosentyx Unoready PenSecukinumab12$83,087
XolairOmalizumab11$28,850
Clobetasol Propionate256$9,170
Ketoconazole335$5,411
Fluorouracil72$5,396
Doxycycline Hyclate152$2,818
Triamcinolone Acetonide174$2,532
Fluocinolone Acetonide53$2,174
Desonide35$2,125
Betamethasone Valerate67$1,628
Clindamycin Phosphate46$1,506
MethotrexateMethotrexate Sodium82$1,260

Paid to pharmacies, not to this prescriber.

Other dermatology in Corinth

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →